Anti-Ki/anti-PA28γ autoantibodies contribute to the HEp-2 indirect immunofluorescence nuclear speckled pattern

Clin Chem Lab Med. 2022 Nov 30;61(3):435-441. doi: 10.1515/cclm-2022-0858. Print 2023 Feb 23.

Abstract

Objectives: Antinuclear antibodies (ANAs) are associated with several autoimmune diseases. Indirect immunofluorescence (IIF) on human epithelial type 2 (HEp-2) cells is the golden standard for ANA detection in the clinic. In case of a positive HEp-2 IIF test result, follow-up tests are done to determine autoantibody specificity. For a fraction of the HEp-2 IIF-positive samples, the nature of the autoantigens remains uncharacterized. Our objective was to characterize autoantigens in such samples.

Methods: To characterize autoantigens in an unbiased way, we combined protein immunoprecipitation with liquid chromatography (LC) tandem mass spectrometry (MS/MS) sequencing.

Results: Using such approach we detected the Ki antigen, also referred to as PA28γ, in the immunoprecipitate of serum samples of three individuals with an autoimmune disease. The HEp-2 nuclear speckled IIF fluorescent signal of all three serum samples was abolished after pre-absorption of the serum with recombinant Ki antigen, confirming that autoantibodies against Ki underlie the HEp-2 IIF signal.

Conclusions: Our data suggest that anti-Ki autoantibodies can underlie a nuclear speckled HEp-2 IIF pattern.

Keywords: HEp-2 IIF; Ki antigen; autoantibodies; proteasome activator 28γ (PA28γ).

MeSH terms

  • Antibodies, Antinuclear
  • Autoantibodies*
  • Autoantigens
  • Autoimmune Diseases* / diagnosis
  • Fluorescent Antibody Technique, Indirect / methods
  • Humans
  • Tandem Mass Spectrometry

Substances

  • Autoantibodies
  • Ki antigen
  • Autoantigens
  • Antibodies, Antinuclear